SCHEMBL13298643

SCHEMBL13298643

FC(F)(F)c1ccc2c(-c3ccc(-c4cccc5ccccc45)cc3)c3ccc(C(F)(F)F)cc3c(-c3cccc4ccccc34)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
ESR1 P03372 1/20 0.40
PSD A5PKW4 1/20 0.39
ENPP1 P22413 5/20 0.39
SCN5A Q14524 1/20 0.39
SCN9A Q15858 1/20 0.39
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP1B1 Q16678 1/20 0.38
EPHX2 P34913 1/20 0.38
KIF11 P52732 2/20 0.38
PPARG P37231 2/20 0.37
PPARA Q07869 2/20 0.37
CNR2 P34972 1/20 0.37
KCNQ3 O43525 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13298635 1.00 HDAC8 (0.40) HDAC8HDAC6ESR1PSDENPP1
SCHEMBL13298640 1.00 HDAC8 (0.40) HDAC8HDAC6ESR1PSDENPP1
SCHEMBL13298634 0.93 ESR1 (0.45) ESR1PSDENPP1CA12CA1
SCHEMBL14026046 0.93 ENPP1 (0.43) HDAC8HDAC6ESR1PSDENPP1
SCHEMBL13298630 0.91 PSD (0.44) ESR1PSDCYP1A1CYP1A2CYP1B1
SCHEMBL13298632 0.91 PSD (0.44) ESR1PSDCYP1A1CYP1A2CYP1B1
SCHEMBL13298637 0.91 ESR1 (0.43) HDAC8HDAC6ESR1ENPP1SCN5A
SCHEMBL13298641 0.91 ESR1 (0.43) HDAC8HDAC6ESR1ENPP1SCN5A
SCHEMBL13298646 0.91 ESR1 (0.43) HDAC8HDAC6ESR1ENPP1SCN5A
SCHEMBL13298636 0.90 ESR1 (0.43) HDAC8ESR1PSDCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same DONGJIN SEMICHEM CO., LTD (KR) 2010-06-03 US disclosed
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same DONGJIN SEMICHEM CO., LTD (KR) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same TRPA1, TRPM2, TRPM4 HDAC8 3443/4885HDAC6 4619/4885ESR1 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.